Norda ASA (OTCNO: NORD)
Health Care · Biotechnology · NO
Nkr85.10
— today · +3.5% 1Y
Norda ASA (OTCNO: NORD) operates in the Biotechnology industry within the Health Care sector. The company is valued at $45.37M.
Over the last twelve months the share price has gained 3.5%, trading between 81.00 and 100.00.
Tweenvest scores Norda ASA across four factors: quality 62/100, value 69/100, growth 84/100, dividend 91/100. Its strongest factor is dividend.
NORD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.37M
- Revenue (TTM)
- $32.73M
- P/E
- 3.47
- EPS
- 24.54
- Dividend yield
- 30.55%
- Beta (5Y)
- -0.21
- 52-week high
- Nkr100.00
- 52-week low
- Nkr81.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.13M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PanGen Biotech Inc.KOSDAQ: A222110 | $48.17M | ₩4,800.00 | -0.10% |
| Elicio Therapeutics, Inc.NasdaqCM: ELTX | $47.57M | $1.81 | -2.16% |
| Celularity Inc.NasdaqCM: CELU | $47.38M | $1.46 | -0.68% |
| CervoMed Inc.NasdaqCM: CRVO | $45.66M | $3.28 | +8.61% |
| Werewolf Therapeutics, Inc.NasdaqCM: HOWL | $45.10M | $0.91 | -1.95% |
| GenMont Biotech IncorporationTWSE: 3164 | $44.55M | NT$16.50 | +1.23% |
| Harvard Apparatus Regenerative Technology Inc.OTCPK: HRGN | $44.42M | $2.19 | +11.17% |
| Adocia SAENXTPA: ADOC | $44.04M | €2.01 | -2.71% |
Figures last refreshed Oct 4, 2026.